Join HSANZ
If you are interested in advertising for a job vacancy, click here for our terms and conditions.
For Nurse positions, see Nurses News
Haematologist – Malignant haematology, Te Pūriri o te Ora - Cancer and Blood Service
Position closes 8 June 2023
Te whiwhinga mahi | The Opportunity
Te Pūriri o Te Ora Regional Cancer and Blood Service, based at Auckland City Hospital, is the leading provider of cancer care in the Auckland region, serving a large and varied population of around 1.7 million people.
As a Haematologist, you will utilize your skills and experience in malignant haematology while having the opportunity to be involved in the full spectrum of haematological cancer care. Your extensive work experience in clinical haematology with sub-speciality experience and research in aspects of general and malignant haematology including the treatment of acute leukaemia are keys to your success in this role. However, we would also be interested to have a conversation if you have interests and experience with other sub specialties.
You will be a part of the Clinical Haematology Service, providing secondary haematology services to the central Auckland area and tertiary services including treatment of acute leukaemia, high grade lymphoma and autologous/allogeneic stem cell transplant for the greater Auckland region (population greater than 1.5 million). You will be working with a well-established thrombosis unit and bleeding disorder program including dedicated haemophilia care, as well as LabPlus who provides integrated and comprehensive laboratory support for the clinical service. This service also comprises of an extensive clinical trials unit and has links with medical and radiation oncology programs. In this role, you will have the opportunity to contribute to the teaching programme for undergraduate students, registrars and hospital staff
For all aspects of this role and experience/knowledge required please see the position description.
For more information about this role please contact Elizabeth Shaw, Service Clinical Director - Haematology at eshaw@adhb.govt.nz or Leanne Berkahn, Medical Lead at LeanneBerk@adhb.govt.nz
Ko wai mātou | Our Organisation
We are Te Whatu Ora Te Toka Tumai Auckland. We provide health and disability services to more than half a million people living in central Auckland, regional services for Northland and greater Auckland, and specialist national services for the whole of New Zealand. Our main sites are Auckland City Hospital, Greenlane Clinical Centre and Starship Children’s Hospital, located in central Auckland.
We are part of Te Whatu Ora – Health New Zealand, the overarching organisation for New Zealand’s National Health Service. Te Whatu Ora leads the day-to-day running of the health system, with functions delivered at local, district, regional and national levels.
We are committed to upholding Te Tiriti o Waitangi and providing culturally safe care. We value role modelling manaakitanga as demonstrated by Ngāti Whātua in the gifting of their whenua on which our hospitals stand. We aspire to having a workforce reflective of the communities we serve and achieving equitable outcomes for all.
Nga Pūkenga Motuhake | Important Skills
To be successful in this role-
You must have or be eligible for vocational and / or Locum Tenens registration in Internal Medicine and ideally Pathology with the Medical Council of New Zealand (www.mcnz.org.nz).
He aha ngā painga o tēnei mahi mōu | Why you will enjoy working here
We recognise there is more to life than mahi | work, and we encourage and provide access to all our staff several services and benefits to support themselves whilst they are employed within Te Toka Tumai Auckland. You will also enjoy:
For more information on what we offer, please click here.
Me pēhea te tuku tono | How to apply
Please submit your application online here, outlining your experience and motivation to apply to this role.
If you have any queries about accessibility, or technical issues with the online process, please contact Nisha Karipoth, recruitment Consultant at nkaripoth@adhb.govt.nz to discuss how we can best support your application.
Click here to view details about our recruitment process
Immigration/Visa Support
Immigration NZ has introduced a new Accredited Employer Work Visa system from 4 July 2022 that includes a simplified residency process for health workers on the new “Green List” of occupations – and this position is one of those designated critical positions! For successful candidates offered a position with us who require a Work Visa, we will provide support with their Visa application. Here are the links to two key pages of NZ Immigration's official site for more information: Immigration NZ Accredited Employer Work Visa and Immigration NZ Green List Occupation
Haematology Clinical Research Fellow (Lymphoma, Myeloma, Leukaemia/MDS)
Positions available from February 2024 (negotiable start dates) 12 months, with preference for candidates seeking extensions to 2 years subject to satisfactory performance
Essential criteria
completed (or in the final/penultimate year of training) as a Clinical Haematologist
post-FRCPath examination (UK candidates)
registered with the Australian Health Practitioners Regulatory Authority (or eligible for registration – visit https://www.medicalboard.gov.au/Registration/International-Medical-Graduates.aspx for further information)
excellent clinical and interpersonal skills
Desirable criteria
• demonstrated interest in clinical research
Position description
You will play an integral role in the function of a busy clinical trials unit with >30 studies ranging from phase I-III across lymphoma, myeloma and leukaemia. We have an active cellular therapy program including autologous and allogeneic CAR T-cell trials. The hospital is Perth’s largest public tertiary hospital, located 5km west of central Perth.
For an overview of our department and trials currently open visit www.bloodcancerwa.org.au
Key responsibilities
Identification, recruitment, and care of patients on clinical trials
Disease subtype focused outpatient clinics
Design, presentation and publication of clinical research
Why join us?
Work in one of the most active Haematology clinical trials unit in the world
Mentoring opportunities with leaders in the field
Our fellows have been extremely productive with multiple oral presentations at ASH, high impact first author publications and involvement in investigator initiated trials
Protected research time, with projects tailored to suit the disease interests of the successful candidate
Work/life balance: no rostered after hours or weekend commitment
Enjoy a great quality of life: Perth is clean, safe, family friendly, has excellent schools, a vibrant arts/dining scene, and sunny climate well suited to an outdoor lifestyle
Applications and further information
Prof Chan Cheah email chan.cheah@health.wa.gov.au
Northern Beaches Hospital Expression of Interest - VMO Clinical Haematology
Closes: Monday 1 st May 2023 Northern Beaches Hospital (NBH) is currently seeking expressions of interest for the position of Visiting Medical Officer, Clinical Hematology As a valued member of our Haematology team, you will provide expertise in the clinical management and treatment of patients in the Northern Beaches Hospital (NBH) Haematology Unit, whilst maintaining safe, effective and professional care for hematology patients within the Northern Beaches community. You will provide support and promote seamless continuity of care between inpatient and outpatient services. Key responsibilities:
To be successful in the role you will:
To Apply: Please send a cover letter addressing the selection competencies and your CV to Chief Medical Officer, A/Prof. Peter Thomas at Peter.Thomas@healthscope.com.au by COB Monday 1 st May 2023.
For any enquires please contact Dr Amber Biscoe, Head of Hematology at Northern Beaches Hospital on 02 9105 5000
Fellows in Haematology: Available from February 2024
Exciting positions are available at Royal Perth Hospital (RPH) for Fellows/ Senior Registrars in clinical and laboratory haematology available from February 2024 until January 2025.
The 2 positions are suitable for trainees who have completed, or are completing, RACP and RCPA joint training or equivalent in 2023 or 2024 and wish to develop further expertise in clinical research. Applicants must have completed part 1 FRACP.
Position 1 is a Clinical Trials Fellow with the opportunity to coordinate and co-lead clinical trials across the spectrum of haematology malignancies. The clinical trials range from phase I to phase III, including first-in- human studies. The department focus is on acute myeloid leukaemia, myeloma, lymphoma and myeloproliferative disorders.
Position 2 is a Cellular Therapy Fellow. Working with Cell and Tissue Therapies of Western Australia (CTTWA), a facility on site at RPH responsible for stem cell processing for autologous stem cell transplants and the development of cellular therapies. The haematology department works closely with CTTWA and is actively involved with a CAR-T cell therapy developmental program using autologous and trials of “off the shelf” allogeneic CAR-T cells.
RPH Haematology Fellows will also have the opportunity to participate in translational research projects in collaboration with Professor Wendy Erber and her team at the University of Western Australia. Fellows have recently been successful applicants for research grants looking at:
The role of plasma cfDNA (liquid biopsies) in the diagnosis and management of acute myeloid leukaemia and myelodysplastic syndromes.
Chromosomal analysis of haematological malignancies by imaging flow cytometry for CLL and myeloma using the world-first immunoflow-FISH method.
Platelet transcriptome as novel biomarker in myeloproliferative neoplasms.
Responsibilities also include a shared service commitment with other Fellows and advanced Trainees in performing and reporting bone marrow biopsies, reporting laboratory results including peripheral bloods and flow cytometry. Clinical responsibilities include inpatient care, outpatients and a consultative service and an on call commitment.
Please forward an expression of interest and a CV by 31 May 2023 with the names and contact details (email and telephone number) of 2 referees to:
Professor Michael Leahy Head of Haematology, Royal Perth Hospital, Perth, Western Australia michael.leahy@health.wa.gov.au+61 438 384 482
ASSOCIATE CLINICAL HAEMATOLOGIST
ALBURY-WODONGA HEALTH and BORDER MEDICAL ONCOLOGY & HAEMATOLOGY
ALBURY WODONGA
Border Medical Oncology and Haematology (BMOH) is a thriving and well-organised medical oncology & haematology practice based in Albury-Wodonga. We are seeking a second Haematologist to join our practice on a full time basis.
The practice sees both public and private patients across a broad range of tumour types. We service a regional population of approximately 250,000 people and provide outreach clinics to Wangaratta and Deniliquin. We are based in the Albury Wodonga Regional Cancer and Wellness Centre (AWRCC) , which includes state of the art day ward, inpatient wards and radiotherapy department. The centre is located on the Albury campus of Albury Wodonga Health.
We have an established, award winning clinical research department allowing our patients access to a broad range of clinical trials. Our research unit was the recipient of an $18.5 million over 5 years from the Medical Research Future Fund Grant in collaboration with the regional Trials Network Victoria to improve outcomes in cancer patients across regional Victoria
Multidisciplinary clinics are established for common malignancies as well as teleconferencing and mentoring links with metropolitan centres for the co-management of less common tumours. Albury Wodonga Health and the AWRCC is an associate site of the Victorian Comprehensive Cancer Centre enabling clinical, research and educational partnerships
Haematology consists of non-malignant and malignant haematology with well-established day chemotherapy and inpatient facilities to support growing needs. There is an advanced trainee in haematology, and close links with the combined haematology service at Peter MacCallum Cancer Centre and Royal Melbourne Hospital.
The successful applicant will have the unique opportunity to become an associate of the Border Medical Oncology and Haematology practice and a Visiting Medical Officer at the Border Cancer Hospital and Albury Wodonga Health. Opportunities exist for a conjoint appointment with the University of NSW rural medical school.
Requirements
Essential:
• FRACP (Haematology) Completion of advanced training in Haematology.
• Specialist registration in adult medicine (Physician) and Haematology with the Australian Health Practitioner Registration Authority (AHPRA)
• Demonstrated capacity in the efficient and effective day-to-day management of haematology patients and a commitment to best practice care, including a commitment to clinical research.
• Demonstrated excellence in written and verbal communication skills.
• Commitment to a multidisciplinary approach to patient management.
Enough about work. Albury-Wodonga provides an envious lifestyle in one of the most beautiful regions of Australia. (The secret seems to be out as it is one of the fastest growing cities in Australia. There is an abundance of space, clean air, mountains, ski resorts, rivers, wineries, restaurants, national parks and numerous other recreational opportunities. The city has a diverse economy and affordable housing. Read more about how we bench mark on this link. https://smart-cities.dashboard.gov.au/allcities/overview
The region boasts a number of excellent secondary and tertiary educational facilities. An efficient regional airport provides easy access to Sydney and Melbourne allowing easy face to face interaction with city colleagues and participation in state and national committees.
Enquiries:
Contact: Dr Craig Underhill, Border Medical Oncology Phone: 02 60641515
Fax: 02 60641516 or Email:
Direct Applications Only
This vacancy is NOT open to any agencies or employment consultants, regardless of their status.
A position is available at Royal Perth Hospital (RPH) for a Fellow/ Senior Registrar in clinical and laboratory haematology available from 24 April 2023 until February 2024 or depending on applicants availability.
The position is suitable for trainees who have completed, or are completing, RACP and RCPA joint training in 2023 or 2024 and wish to develop further expertise in clinical research. Applicants must have completed part 1 FRACP.
The department is involved with clinical trials across the spectrum of haematology malignancies with a focus on acute myeloid leukaemia, myeloma and lymphoma.
Cell and Tissue Therapies of Western Australia (CTTWA) is a facility on site at RPH responsible for stem cell processing for autologous stem cell transplants and the development of cellular therapies. The haematology department works closely with CTTWA which is currently running trials assessing the immunomodulatory effects of mesenchymal stem cells in myelodysplasia, inflammatory bowel disease and organ transplant rejection.
CTTWA is also actively involved with a CAR-T cell therapy developmental program using autologous and “off the shelf” allogeneic CAR-T cells.
RPH Haematology Fellows will have the opportunity to participate in research projects in collaboration with Professor Wendy Erber and her team at the University of Western Australia. Fellows have recently been successful applicants for research grants looking at:
The role of plasma DNA (liquid biopsies) in the diagnosis and management of acute myeloid leukaemia and myelodysplastic syndromes.
Improving the detection of 17p deletion in chronic lymphocytic leukaemia and multiple myeloma using novel immunoflow-FISH.
Genomic instability in myeloproliferative neoplasms.
Responsibilities include a shared service commitment with other fellows and advanced trainees in performing and reporting bone marrow biopsies, reporting laboratory results including peripheral bloods and flow cytometry. Clinical responsibilities include inpatient care, outpatients and a consultative service and an on call commitment.
Please forward an expression of interest and a CV by 30 April 2023 with the names and contact details (email and telephone number) of 2 referees to:
Professor Michael Leahy Head of Haematology, Royal Perth Hospital, Perth, Western Australia michael.leahy@health.wa.gov.au
+61 438 384 482 Click here for information
Staff Specialist - Haematology - Dubbo
Employment Type: Permanent Full Time Position Classification: Staff Specialist
Remuneration: $246,059 - $332,434 pa (These amounts are inclusive of superannuation and allowances) Hours per week: 40
Applications Close: 16 October 2022 – 11.59 pm
About the opportunity
Dubbo Health Service is now looking for a Full Time Staff Specialist in Haematology to join the team in Dubbo.
The Staff Specialist will join a fast growing and dynamic multi-disciplinary team who are providing services to the biggest rural health district in NSW, and at 250,000 sq km is one of the largest in the country. Given the large geographical area encompassed by our district, improved delivery of service to these rural and remote communities is a focus of the facility, including the provision of clinical trials.
The current Haematology team at Dubbo comprises of two Haematologists and one Clinical Nurse Specialist. This is largely an outpatient service, with rare inpatients, but planning to move to limited inpatient service with increased staffing over time. This position will join the team and will be based in Dubbo at the new Western Cancer Centre with opportunities available to do lab work and outreach clinics.
The Western Cancer Centre is a brand new centre that opened recently and provides holistic services to Western NSW. The centre has expanded and upgraded clinical services including 16 Chemotherapy chairs, Radiotherapy services, and PET scanner.
Click here for the Position Description and Statement of Duties
For role related queries, contact Dr Sue Moreton via email or phone 02 6809 6209.
How do I apply for this role?
Apply for this position via our eCredential website here. Please address the selection criteria listed in the position description.
For full information click here
© 2023 Haematology Society of Australia & New Zealand All Rights Reserved.
Privacy Policy